or Try an Advanced Search...

    Technical Analysis for CNTG - Centogene N.V.

    Grade Last Price % Change Price Change
    F 0.48 2.11% 0.01
    CNTG closed up 2.11 percent on Tuesday, April 23, 2024, on approximately normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical CNTG trend table...
    Date Alert Name Type % Chg
    1,2,3 Retracement Bearish Bearish Swing Setup 0.00%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Gapped Up Strength 0.00%
    Oversold Stochastic Weakness 0.00%
    Shooting Star Candlestick Bearish 2.11%
    Pocket Pivot Bullish Swing Setup 2.11%
    Volume Surge Other 2.11%
    Doji - Bearish? Reversal 2.11%
    Older End-of-Day Signals for CNTG ...

       Recent Intraday Alerts

    Alert Time
    Possible Inside Day about 6 hours ago
    Gap Up Closed about 6 hours ago
    60 Minute Opening Range Breakdown about 6 hours ago
    Reversed from Up about 6 hours ago
    10 DMA Resistance about 9 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    CNTG Chart by TradingView
    Basic chart:

    Profile

    Centogene BV is a commercial-stage company. It focuses on rare diseases that transform real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies. It operates through the following two segments: Pharmaceutical and Diagnostics. The Pharmaceutical segment provides services to pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery and patient monitoring. The Diagnostics segment provides targeted genetic sequencing and diagnostics services. The company was founded by Arndt Rolf and Christoph Ehlers in 2006 and is headquartered in Rostock, Denmark.
    Classification
    Sector: Healthcare
    Industry: Diagnostics & Research
    Keywords: Pharmaceutical Rare Diseases Biomarkers Recruitment Pharmaceutical Partners Diagnostics Services

    Is CNTG a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 2 Centogene receives Nasdaq non-compliance letter
    Apr 2 CENTOGENE Receives Nasdaq Non-Compliance Notice
    Feb 29 CENTOGENE Collaborates on Research Published in Science Showing Immunopathological Landscape of Human Pre-TCRα Deficiency
    Feb 28 Centogene to explores strategic alternatives, gets Nasdaq delisting notice; shares plunge
    Feb 28 CENTOGENE Explores Strategic Alternatives
    Feb 28 CENTOGENE Announces Receipt of Nasdaq Notice of Delisting and Intention to Request a Hearing
    Jan 24 CENTOGENE Receives French Research Tax Credit Accreditation
    Jan 23 CENTOGENE and The Michael J. Fox Foundation Announce Research Project to Validate Genetic Risk Factors of Parkinson’s Disease Using Multiomics
    Jan 18 Centogene says FY revenue is expected to be between €48.5 million €49.0 million
    Jan 18 CENTOGENE Announces Preliminary Full Year 2023 Revenue
    See more CNTG news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.1
    52 Week Low 0.431
    Average Volume 69,193
    200-Day Moving Average 1.04
    50-Day Moving Average 0.70
    20-Day Moving Average 0.60
    10-Day Moving Average 0.51
    Average True Range 0.07
    RSI (14) 31.03
    ADX 40.98
    +DI 12.65
    -DI 28.37
    Chandelier Exit (Long, 3 ATRs) 0.54
    Chandelier Exit (Short, 3 ATRs) 0.64
    Upper Bollinger Bands 0.80
    Lower Bollinger Band 0.40
    Percent B (%b) 0.2
    BandWidth 66.83
    MACD Line -0.08
    MACD Signal Line -0.07
    MACD Histogram -0.0092
    Fundamentals Value
    Market Cap 13.38 Million
    Num Shares 27.9 Million
    EPS -1.56
    Price-to-Earnings (P/E) Ratio -0.31
    Price-to-Sales 0.60
    Price-to-Book 0.86
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.57
    Resistance 3 (R3) 0.58 0.55 0.55
    Resistance 2 (R2) 0.55 0.53 0.55 0.55
    Resistance 1 (R1) 0.52 0.52 0.50 0.51 0.54
    Pivot Point 0.49 0.49 0.49 0.49 0.49
    Support 1 (S1) 0.46 0.47 0.45 0.45 0.42
    Support 2 (S2) 0.43 0.46 0.43 0.41
    Support 3 (S3) 0.40 0.43 0.41
    Support 4 (S4) 0.39